Pharmigene (ROCO:7595) Pre-Tax Income : NT$-82.8 Mil (TTM As of Dec. 2024)

Pharmigene Pre-Tax Income Chart

Pharmigene Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Pre-Tax Income	Get a 7-Day Free Trial									-19.93	-28.66	-43.98	-48.65	-34.18

Competitive Comparison of Pharmigene's Pre-Tax Income

For the Diagnostics & Research subindustry, Pharmigene's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmigene's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Pharmigene's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Pharmigene's Pre-Tax Income falls into.

Pharmigene Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Pharmigene's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as

Pharmigene's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-82.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmigene  (ROCO:7595) Pre-Tax Income Explanation

Pharmigene's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

During the past 8 years, Pharmigene's highest Pretax Margin was -9.37%. The lowest was -71.08%. And the median was -25.15%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmigene Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Pharmigene's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmigene Business Description